Retrospective analysis of utilization patterns and cost implications of coxibs among seniors in Quebec, Canada: What is the potential impact of the withdrawal of rofecoxib?

Rahme, Elham; Hunsche, Elke; Toubouti, Youssef; Chabot, Isabelle

doi:10.1002/art.21696

Cited by 3 publications

(1 citation statement)

References 39 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The choice of algorithms was made according to the most prevalent chronic pain syndromes in the QPR (Table ). Although previous administrative database studies reported algorithms for postherpetic neuralgia, osteoarthritis, migraine, headaches, rheumatoid arthritis, irritable bowel syndrome, and systemic lupus erythematous, the prevalence of such conditions was ≤2.5% in our sample (Table ) and did not allow us to estimate validity statistics. The validity of single pain codes (307.8, 338, 338.2, or 338.4) was also investigated (end of Table ).…”

Section: Methodsmentioning

confidence: 69%

Is the Quebec provincial administrative database a valid source for research on chronic non‐cancer pain?

Lacasse

Ware

Dorais³

et al. 2015

Pharmacoepidemiology and Drug

View full text Add to dashboard Cite

show abstract

Section: Methodsmentioning

confidence: 69%

Is the Quebec provincial administrative database a valid source for research on chronic non‐cancer pain?

Lacasse

Ware

Dorais³

et al. 2015

Pharmacoepidemiology and Drug

View full text Add to dashboard Cite

show abstract

Changes in physicians' practice of prescribing cyclooxygenase-2 inhibitor after market withdrawal of rofecoxib: A retrospective study of physician-patient pairs in Taiwan

Hsiao¹,

Tsai²,

Huang³

2009

Clinical Therapeutics

View full text Add to dashboard Cite

Validity of Algorithms for Identification of Individuals Suffering from Chronic Noncancer Pain in Administrative Databases: A Systematic Review

et al. 2020

View full text Add to dashboard Cite

Background Secondary analysis of health administrative databases is indispensable to enriching our understanding of health trajectories, health care utilization, and real-world risks and benefits of drugs among large populations. Objectives This systematic review aimed at assessing evidence about the validity of algorithms for the identification of individuals suffering from nonarthritic chronic noncancer pain (CNCP) in administrative databases. Methods Studies reporting measures of diagnostic accuracy of such algorithms and published in English or French were searched in the Medline, Embase, CINAHL, AgeLine, PsycINFO, and Abstracts in Social Gerontology electronic databases without any dates of coverage restrictions up to March 1, 2018. Reference lists of included studies were also screened for additional publications. Results Only six studies focused on commonly studied CNCP conditions and were included in the review. Some algorithms showed a ≥60% combination of sensitivity and specificity values (back pain disorders in general, fibromyalgia, low back pain, migraine, neck/back problems studied together). Only algorithms designed to identify fibromyalgia cases reached a ≥80% combination (without replication of findings in other studies/databases). Conclusions In summary, the present investigation informs us about the limited amount of literature available to guide and support the use of administrative databases as valid sources of data for research on CNCP. Considering the added value of such data sources, the important research gaps identified in this innovative review provide important directions for future research. The review protocol was registered with PROSPERO (CRD42018086402).

show abstract

Retrospective analysis of utilization patterns and cost implications of coxibs among seniors in Quebec, Canada: What is the potential impact of the withdrawal of rofecoxib?

Abstract: Conclusion. Celecoxib appears to be a more expensive therapeutic option than rofecoxib due to a relatively higher daily dose and tablet consumption.

Cited by 3 publications

References 39 publications

Is the Quebec provincial administrative database a valid source for research on chronic non‐cancer pain?

Is the Quebec provincial administrative database a valid source for research on chronic non‐cancer pain?

Changes in physicians' practice of prescribing cyclooxygenase-2 inhibitor after market withdrawal of rofecoxib: A retrospective study of physician-patient pairs in Taiwan

Validity of Algorithms for Identification of Individuals Suffering from Chronic Noncancer Pain in Administrative Databases: A Systematic Review

Contact Info

Product

Resources

About